Partnering & Outsourcing Editorial

  1. A New Barometer For Clinical Outsourcing Performance 10/16/2024

    Interested in how some of the top publicly traded clinical development outsourcing companies are doing in the market? Andrew Schafer may be able to help with his Schafer Clinical Development Index (SCDI).

  2. The Value Of A High-Performing Regulatory Function Within A CRO 9/25/2024

    Consultant Pete Embley discusses the value a regulatory expert brings to both CROs and sponsors alike.

  3. Clinical Development Negotiation: How Can A Notebook, Chronodex, And Compendium Help Enhance Partnerships? 9/12/2024

    What can three tools — a notebook, a chronodex, and a compendium — teach clinical research professionals about successful negotiation and collaboration? RHIEOS-Ventures and Dealligence's Larry Ajuwon explains.

  4. Dedicated Trialist, Nurse Navigators Help Advance Cancer Therapy Into Accelerated Approval 9/11/2024

    Thoracic medical oncologist Sally Lau, MD Lau discusses her role as a principal investigator, from the benefits of the FDA’s accelerated approval pathway to best practices for retaining a challenging patient population.

  5. A 5-Step Approach To Strengthen Clinical Trial Partnerships In Low- And Middle-Income Countries 8/30/2024

    To find suppliers and partners for our clinical trial programs, we need to go beyond just selecting the best offer and then managing them. For virtual organizations in particular, we must strive to be the partner of choice. 

  6. The Small Biotech's Checklist For FIH Trials 8/27/2024

    Getting medicine to its first patients is enormously complex with many players and moving parts. These are the critical steps.

  7. Are You Afraid Of Adopting New Outsourcing Models? 8/21/2024

    Pricing strategies for outsourcing clinical services have evolved over the years, yet many sponsors are reluctant to change from their status quo. That may change, though, as CROs begin to add technology and site networks to their offerings. 

  8. Clinical Trial QA Strategies In Low- And Middle-Income Countries 8/9/2024

    This author shares key learnings and insights around quality assurance coming out of Gates MRI's vaccine clinical trials in low- and middle-income countries.

  9. Government Contract Advances Walgreens In Clinical Space 8/1/2024

    Walgreen’s new $25 million deal with BARDA (Biomedical Advanced Research and Development Authority) is a huge win for the pharmacy chain. John Campbell, head of DCTs at Walgreens, explains the ins and outs of the study and what could be next for the company regarding its clinical trials division.

  10. Why Moving More Cancer Trials Into The Community Benefits Patients And Sponsors 7/29/2024

    Amita Patnaik, MS, FRCPC recounts the growth and necessity of START’s locations and site network amid the perpetual need to bring clinical research, especially for cancer, closer to patients.